cagrilintide and retatrutide FDA SAYS CANNOT BE USED IN COMPOUNDING FDA SENT 12 NEW WARNING LETTERS TODAY 5 peptide/unapproved-drug letters 4 pharmaceutical/API manufacturing CGMP letters 2 food-import FSVP letters 1 mixed CGMP + Cagrilinitide 10 mg – rx vitamins Sharps Bin:Yellow

cagrilintide and retatrutide FDA SAYS CANNOT BE USED IN COMPOUNDING FDA SENT 12 NEW WARNING LETTERS TODAY 5 peptide/unapproved-drug letters 4 pharmaceutical/API manufacturing CGMP letters 2 food-import FSVP letters 1 mixed CGMP + Cagrilinitide 10 mg – rx vitamins Sharps Bin:Yellow

Cagrilinitide 10 mg – Pharma-one Peptides

Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study

rx vitamins

Sharps Bin:Yellow

Hematocrit, reticulocyte count, vitamin B 12, folate and iron levels should be obtained prior to treatment